HRP20100560T1 - Minimalna dnk sekvenca koja djeluje kao izolator kromatina i njena upotreba u ekspresiji proteina - Google Patents

Minimalna dnk sekvenca koja djeluje kao izolator kromatina i njena upotreba u ekspresiji proteina Download PDF

Info

Publication number
HRP20100560T1
HRP20100560T1 HR20100560T HRP20100560T HRP20100560T1 HR P20100560 T1 HRP20100560 T1 HR P20100560T1 HR 20100560 T HR20100560 T HR 20100560T HR P20100560 T HRP20100560 T HR P20100560T HR P20100560 T1 HRP20100560 T1 HR P20100560T1
Authority
HR
Croatia
Prior art keywords
use according
interest
polypeptide
human
subunit
Prior art date
Application number
HR20100560T
Other languages
English (en)
Croatian (hr)
Inventor
Chatellard Philippe
Imhof Markus
Original Assignee
Merck Serono Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Serono Sa filed Critical Merck Serono Sa
Publication of HRP20100560T1 publication Critical patent/HRP20100560T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HR20100560T 2003-10-21 2004-10-20 Minimalna dnk sekvenca koja djeluje kao izolator kromatina i njena upotreba u ekspresiji proteina HRP20100560T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03103890 2003-10-21
PCT/EP2004/052591 WO2005040384A1 (en) 2003-10-21 2004-10-20 Minimal dna sequence acting as a chromatin insulator and its use in protein expression

Publications (1)

Publication Number Publication Date
HRP20100560T1 true HRP20100560T1 (hr) 2010-11-30

Family

ID=34486337

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20100560T HRP20100560T1 (hr) 2003-10-21 2004-10-20 Minimalna dnk sekvenca koja djeluje kao izolator kromatina i njena upotreba u ekspresiji proteina

Country Status (17)

Country Link
US (1) US8133699B2 (pl)
EP (1) EP1675956B1 (pl)
JP (1) JP4745972B2 (pl)
AT (1) ATE484591T1 (pl)
AU (1) AU2004284243B2 (pl)
CA (1) CA2541523A1 (pl)
CY (1) CY1110868T1 (pl)
DE (1) DE602004029598D1 (pl)
DK (1) DK1675956T3 (pl)
ES (1) ES2354160T3 (pl)
HR (1) HRP20100560T1 (pl)
IL (1) IL175021A (pl)
NO (1) NO338767B1 (pl)
PL (1) PL1675956T3 (pl)
PT (1) PT1675956E (pl)
SI (1) SI1675956T1 (pl)
WO (1) WO2005040384A1 (pl)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1395669T3 (da) 2001-01-26 2009-11-16 Selexis Sa Matriks bindingsregioner og fremgangsmåder til anvendelse af disse
ATE399872T1 (de) 2003-03-11 2008-07-15 Serono Lab Expressionvektoren, die den promotor des ie2-gens des maus cytomegalovirus enthalten
AU2004238524B2 (en) * 2003-05-13 2011-06-23 Merck Serono Sa Active variants of the IL-18 binding protein and medical uses thereof
KR101269656B1 (ko) 2003-10-24 2013-05-30 셀렉시스 에스. 에이. Ｍａｒ 서열의 복합 트랜스펙션 방법에 의한 포유동물 세포에서의 고효율 유전자 전달 및 발현
ES2285543T3 (es) 2003-11-05 2007-11-16 Ares Trading S.A. Procedimiento para la purificacion de la proteina de union a il-18.
ATE375385T1 (de) 2004-03-01 2007-10-15 Ares Trading Sa Verwendung eines serumfreien zellkulturmediums zur produktion von il-18bp in säugerzellen
ES2313367T3 (es) * 2004-06-29 2009-03-01 Ares Trading S.A. Procedimiento para la purificacion de proteina de union al il-18.
CA2609060C (en) * 2005-06-03 2014-07-15 Urs Weber Production of recombinant il-18 binding protein
PT1891088E (pt) 2005-06-10 2011-12-19 Ares Trading Sa Processo para a purificação da proteína de ligação il-18
EP1760092A1 (en) * 2005-08-26 2007-03-07 Applied Research Systems ARS Holding N.V. System for screening cells for high expression of a protein of interest
FR2919616A1 (fr) * 2007-08-02 2009-02-06 Ecole Norm Superieure Lyon Polynucleotides insulateurs derives de l'element d4z4 et leurs utilisations en transgenese
EP2697375B1 (en) 2011-04-13 2017-10-18 National Research Council of Canada Expression system with scaffold attachment region (sar) element from interferon 2
WO2013096056A1 (en) * 2011-12-21 2013-06-27 Danisco Us Inc. Improving fungal gene expression using insulator dna sequences
SG11201500799YA (en) 2012-07-31 2015-03-30 Basil M Hantash Hla g-modified cells and methods
KR101591823B1 (ko) 2013-12-27 2016-02-04 재단법인 목암생명공학연구소 증가된 유전자 발현능을 갖는 발현벡터
US11246896B2 (en) 2015-10-28 2022-02-15 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Tumor-specific adenovirus vectors and therapeutic uses
US10143760B2 (en) * 2015-10-28 2018-12-04 Sangamo Therapeutics, Inc. Liver-specific constructs, factor VIII expression cassettes and methods of use thereof
MA45554A (fr) 2016-07-01 2019-05-08 Resolve Therapeutics Llc Fusions de binucléase optimisées.
CN106754817B (zh) * 2016-11-03 2021-02-05 山西省生物研究院有限公司 一种重组自分泌运动因子的表达方法
CN111315767B (zh) 2017-08-22 2025-03-18 萨纳生物有限责任公司 可溶性干扰素受体及其用途
AU2019272848A1 (en) 2018-05-22 2020-12-03 The Brigham And Women's Hospital, Inc. Gene therapy for alzheimer's disease
AU2019314513B2 (en) 2018-08-03 2026-04-30 Sangamo Therapeutics, Inc. Improved clinical parameters by expression of factor viii
CA3141712A1 (en) 2019-05-24 2020-12-03 The Brigham And Women's Hospital, Inc. Gene therapy for alzheimer's disease
AU2020393917A1 (en) * 2019-11-29 2022-06-23 Paros Bio, Inc. Gene therapy for neurodegenerative disorders
BR112023026176A2 (pt) * 2021-06-16 2024-03-05 Mediphage Bioceuticals Inc Vetores de expressão, vetores livres de sequência bacteriana e métodos de fabricação e uso dos mesmos

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5859205A (en) * 1989-12-21 1999-01-12 Celltech Limited Humanised antibodies
US6113898A (en) * 1995-06-07 2000-09-05 Idec Pharmaceuticals Corporation Human B7.1-specific primatized antibodies and transfectomas expressing said antibodies
US6432700B1 (en) * 1997-03-03 2002-08-13 Cell Genesys, Inc. Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same
US6194152B1 (en) * 1997-08-20 2001-02-27 Dendreon Corporation Prostate tumor polynucleotide compositions and methods of detection thereof
AU1128400A (en) * 1998-10-22 2000-05-08 Medical College Of Georgia Institute, Inc. Long terminal repeat, enhancer, and insulator sequences for use in recombinant vectors
AU776752B2 (en) * 1999-06-30 2004-09-23 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The DNA binding protein and sequence as insulators having specific enhancer blocking activity for regulation of gene expression
ATE399872T1 (de) * 2003-03-11 2008-07-15 Serono Lab Expressionvektoren, die den promotor des ie2-gens des maus cytomegalovirus enthalten
AU2004238524B2 (en) 2003-05-13 2011-06-23 Merck Serono Sa Active variants of the IL-18 binding protein and medical uses thereof
ES2285543T3 (es) 2003-11-05 2007-11-16 Ares Trading S.A. Procedimiento para la purificacion de la proteina de union a il-18.
ATE375385T1 (de) 2004-03-01 2007-10-15 Ares Trading Sa Verwendung eines serumfreien zellkulturmediums zur produktion von il-18bp in säugerzellen
ES2313367T3 (es) * 2004-06-29 2009-03-01 Ares Trading S.A. Procedimiento para la purificacion de proteina de union al il-18.
CA2609060C (en) 2005-06-03 2014-07-15 Urs Weber Production of recombinant il-18 binding protein
PT1891088E (pt) 2005-06-10 2011-12-19 Ares Trading Sa Processo para a purificação da proteína de ligação il-18

Also Published As

Publication number Publication date
DK1675956T3 (da) 2010-11-22
NO338767B1 (no) 2016-10-17
SI1675956T1 (sl) 2010-12-31
IL175021A0 (en) 2006-08-20
AU2004284243B2 (en) 2010-11-04
NO20062315L (no) 2006-07-18
AU2004284243A1 (en) 2005-05-06
JP2007508833A (ja) 2007-04-12
EP1675956A1 (en) 2006-07-05
WO2005040384A1 (en) 2005-05-06
JP4745972B2 (ja) 2011-08-10
PT1675956E (pt) 2010-11-04
ES2354160T3 (es) 2011-03-10
DE602004029598D1 (de) 2010-11-25
US8133699B2 (en) 2012-03-13
US20070134761A1 (en) 2007-06-14
CY1110868T1 (el) 2015-06-10
ATE484591T1 (de) 2010-10-15
CA2541523A1 (en) 2005-05-06
IL175021A (en) 2011-07-31
PL1675956T3 (pl) 2011-06-30
EP1675956B1 (en) 2010-10-13

Similar Documents

Publication Publication Date Title
CA2516157A1 (en) Expression vectors comprising the mcmv ie2 promoter
Suematsu et al. IgG1 plasmacytosis in interleukin 6 transgenic mice.
EP1675956B1 (en) Minimal dna sequence acting as a chromatin insulator and its use in protein expression
ES8407329A1 (es) "metodo para construir una secuencia de adn".
JPH07313170A (ja) 共有結合した細胞調節ポリペプチド
Reff High-level production of recombinant immunoglobulins in mammalian cells
PL209110B1 (pl) Sposób obniżania immunogenności białka fuzyjnego, białko fuzyjne otrzymane takim sposobem, zawierająca je kompozycja farmaceutyczna i kodujący je kwas nukleinowy
ES2564227T3 (es) Elemento de ADN que tiene actividad de aumento de expresión de un gen exógeno
WO2011065935A1 (en) Methods for monoclonal antibody production
US20110287454A1 (en) Methods for monoclonal antibody production
CN103865947A (zh) 一种包含弱化的sv40启动子/二氢叶酸还原酶表达元件的真核表达载体及其构建方法
Lu et al. Rational design of an EGF-IL18 fusion protein: implication for developing tumor therapeutics
KR101955366B1 (ko) 인터페론 베타-엘라스틴 재조합 단백질 및 이의 생산방법
US20090111146A1 (en) Antibody Drug
CN103620034B (zh) 具有来自IFNα2的SAR元件的表达系统
CN104694568B (zh) 动物细胞用表达载体、其制备方法及应用
EP1957660B1 (en) Materials and methods to increase peptide chain expression
KR20210081989A (ko) 동물세포 발현벡터
CA2459013A1 (en) Proteins having effects of controlling cell migration and cell death
Class et al. Patent application title: Expression System With Sar Element From IFNalpha2 Inventors: Yves Durocher (Montreal, CA) Assignees: NATIONAL RESEARCH COUNCIL OF CANADA